ProEncia Biotechnology
ProEncia Biotechnology17
About
What does ProEncia Biotechnology do?
ProEncia Biotechnology is a biopharma startup focused on creating novel, non-invasive products for the treatment and commercialization of periodontal disease. Their pipeline aims to address patients suffering from periodontal disease at all stages of severity.
What is ProEncia Biotechnology's revenue?
StartupHub estimates ProEncia Biotechnology's annual revenue at $455K (range $302K to $1.8M, 69% confidence), based on comparable companies in the sector.
Where is ProEncia Biotechnology headquartered?
ProEncia Biotechnology is headquartered in Minneapolis, Minnesota, USA.
When was ProEncia Biotechnology founded?
ProEncia Biotechnology was founded in 2019.
What industry does ProEncia Biotechnology operate in?
ProEncia Biotechnology operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech, HealthTech.
How many employees does ProEncia Biotechnology have?
ProEncia Biotechnology has approximately 5 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.